Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Daytime cortisol patterns track cognitive decline but not Alzheimer’s disease risk

2

Aug 2026

Daytime cortisol patterns track cognitive decline but not Alzheimer’s disease risk

In 3,895 older adults, moderate daytime cortisol variability was associated with better cognition and slower decline, while the highest daily cortisol exposure was linked to poorer cognition and faster decline. Cortisol patterns differed between Black and White participants, but their relationships with cognition were similar, and none predicted incident Alzheimer’s disease.

Study links higher body fat to lower sperm counts despite normal BMI

2

Aug 2026

Study links higher body fat to lower sperm counts despite normal BMI

Among 1,058 Danish men, higher body fat percentage was associated with lower total sperm count and altered reproductive hormone levels, but not testicular volume. Body fat percentage showed stronger links with several semen measures than BMI or waist-to-height ratio, with the sperm-count association strengthening among men with normal BMI.

Persistent financial hardship tracks with poorer memory and processing speed by midlife

2

Aug 2026

Persistent financial hardship tracks with poorer memory and processing speed by midlife

Researchers linked persistent low income and financial hardship across early and mid-adulthood to poorer processing speed and verbal memory at age 53 in a British birth cohort. Neuroimaging suggested greater vulnerability to later brain atrophy among men, people from disadvantaged childhood backgrounds, and APOE-ε4 carriers, although these subgroup findings require replication.

Cooperative sperm may improve fertilization success across diverse arthropods

31

Jul 2026

Cooperative sperm may improve fertilization success across diverse arthropods

Fertilization is often imagined as a frantic race, with millions of sperm competing for a single prize. But new research by a team of evolutionary biologists from Syracuse University, University of Siena, Italy, and University of Szeged, Hungary, reveals a more surprising reality, where success can depend less on competition and more on cooperation.

AI-powered blood test detects liver cancer across distinct populations

31

Jul 2026

AI-powered blood test detects liver cancer across distinct populations

Researchers at the Johns Hopkins Kimmel Cancer Center validated an artificial intelligence (AI)-powered blood test that accurately detected liver cancer in people from two geographically and biologically distinct populations and also uncovered the underlying biological signals that make the test effective.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.